The efficacy of rebamipide add-on therapy in arthritic patients with COX-2 selective inhibitor-related gastrointestinal events: a prospective, randomized, open-label blinded-endpoint pilot study by the GLORIA study group (Q43936486)

From Wikidata
Jump to navigation Jump to search
scientific article published on 10 January 2013
edit
Language Label Description Also known as
English
The efficacy of rebamipide add-on therapy in arthritic patients with COX-2 selective inhibitor-related gastrointestinal events: a prospective, randomized, open-label blinded-endpoint pilot study by the GLORIA study group
scientific article published on 10 January 2013

    Statements

    The efficacy of rebamipide add-on therapy in arthritic patients with COX-2 selective inhibitor-related gastrointestinal events: a prospective, randomized, open-label blinded-endpoint pilot study by the GLORIA study group (English)
    Masahiro Hasegawa
    Noriyuki Horiki
    Kyosuke Tanaka
    Hiroki Wakabayashi
    Shunsuke Tano
    Masaki Katsurahara
    Atsumasa Uchida
    Yoshiyuki Takei
    Akihiro Sudo
    10 January 2013
    1172-1178

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit